Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02083250
Title Fludarabine/Clofarabine/Busulfan Combined With SAHA in Acute Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

bone marrow cancer

acute lymphoblastic leukemia

acute myeloid leukemia

Therapies

anti-thymocyte globulin

Vorinostat

Busulfan + Clofarabine + Fludarabine

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.